Screening Method for Anti-Colon Cancer Drugs Using Two Sensor Cell Lines With Human Β4-Galactosyltransferase 4 Gene Promoters

Sensors - Switzerland
doi 10.3390/s18082573
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Suppression of Malignant Potentials of A549 Human Lung Cancer Cell Line by Downregulation of the Β4-Galactosyltransferase 1 Gene Expression

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2020English

Promoters With Cancer Cell-Specific Activity for Melanoma Gene Therapy

Acta Naturae
BiochemistryBiotechnologyMolecular MedicineMolecular Biology
2011English

Tumorsphere as an Effective in Vitro Platform for Screening Anti-Cancer Stem Cell Drugs

Oncotarget
Oncology
2015English

Oncogenic Ras Induces Gastrin/CCKB Receptor Gene Expression in Human Colon Cancer Cell Lines LoVo and Colo320HSR

Journal of Laboratory and Clinical Medicine
2003English

Carboranyl Analogues of Ketoprofen With Cytostatic Activity Against Human Melanoma and Colon Cancer Cell Lines

ACS Omega
ChemistryChemical Engineering
2019English

Identification of Candidate Genes Determining Chemosensitivity to Anti-Cancer Drugs of Gastric Cancer Cell Lines

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2009English

Establishment of the New Cell Lines Derived From the Human Renal Cell Carcinoma and Study of the Sensitivity Test of Anti-Cancer Drugs to Cell Lines

Japanese Journal of Urology
Urology
1989English

Reactivity of Monoclonal Antibodies Directed Against Lung Cancer Antigens With Human Lung, Breast and Colon Cancer Cell Lines

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
1993English

Synthetic Approaches for Sulfur Derivatives Containing 1,2,4-Triazine Moiety: Their Activity for in Vitro Screening Towards Two Human Cancer Cell Lines

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy